Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and COVID-19: The Clinical Course and Prognosis of 15 Patients From a Tertiary Care Center.

İnce, Burak; Bektaş, Murat; Koca, Nevzat; Ağargün, BESİM; Zarali, Sibel; Güzey, Damla; Durak, Görkem; Yalçinkaya, YASEMİN; Artim-Esen, Bahar; Gül, AHMET; İnanç, MURAT

doi:10.1097/rhu.0000000000001855

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and COVID-19: The Clinical Course and Prognosis of 15 Patients From a Tertiary Care Center.

İnce B., Bektaş M., Koca N., Ağargün B. F., Zarali S., Güzey D. Y., ...More

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, vol.28, no.6, pp.300-304, 2022 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 28 Issue: 6
Publication Date: 2022
Doi Number: 10.1097/rhu.0000000000001855
Journal Name: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
Page Numbers: pp.300-304
Istanbul University Affiliated: Yes

Abstract

Objective: The aim of this study was to evaluate incidence rates, prognoses, and disease-related factors associated with poor outcomes in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV) who had coronavirus disease (COVID-19).